Solute kinetics with short-daily home hemodialysis using slow dialysate flow rate

Hemodialysis International

Volumn 14, Issue 1, 2010, Pages 39-46

  Kohn, Orly F ^a   Coe, Fredric L ^a   Ing, Todd S ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Phosphorus; Short daily home hemodialysis

Indexed keywords

BETA 2 MICROGLOBULIN; NITROGEN; PHOSPHORUS; POLYETHERURETHAN; POTASSIUM; UREA; DIALYSIS FLUID;

ARTICLE; DIALYSATE; DISTRIBUTION VOLUME; FLOW RATE; HOME DIALYSIS; HUMAN; KIDNEY AGENESIS; MOLECULAR WEIGHT; PROTEIN BLOOD LEVEL; SOLUTE; BLOOD; FEMALE; KIDNEY FAILURE, CHRONIC; MALE; METABOLISM; PROCEDURES;

BETA 2-MICROGLOBULIN; DIALYSIS SOLUTIONS; FEMALE; HEMODIALYSIS, HOME; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PHOSPHORUS; POTASSIUM; UREA;

EID: 77349127075     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2009.00399.x     Document Type: Article

References (30)

1. Woods JD, Port FK, Orzol S. Clinical and biochemical correlates of starting " daily" hemodialysis. Kidney Int 1999, 55:2467-2476.
2. Fagugli RM, Reboldi G, Quintaliani G. Short daily hemodialysis: Blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 2001, 38:371-376.
3. Ayus JC, Mizani R, Achinger SG, Thadhani R, Go AS, Lee S. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: A prospective, controlled study. J Am Soc Nephrol 2005, 16:2778-2788.
4. Williams AW, Chebrolu SB, Ing TS. Early clinical, quality-of-life, and biochemical changes of " daily hemodialysis" (6 dialyses per week). Am J Kid Dis 2004, 43:90-102.
5. Ting GO, Kjellstrand C, Freitas T, Carrie BJ, Zarghamee S. Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis 2003, 42:1020-1035.
6. Nesrallah G, Suri R, Moist L, Kortas C, Lindsay RM. Volume control and blood pressure management in patients undergoing quotidian hemodialysis. Am J Kidney Dis 2003, 42((Suppl 1)):S13-S17.
7. Ing TS, Ronco C, Blagg CR. High-intensity hemodialysis: The wave of the future? Int J Artif Organs 2008, 31:201-212.
8. Clark WB, Turk JE. The NxStage System One. Semin Dial 2004, 17:167-170.
9. Leypoldt JK, Jaber BL, Zimmerman DL. Predicting treatment dose for novel therapies using urea standard Kt/V. Semin Dial 2004, 17:142-145.
10. Gotch F. The current place of urea kinetic modeling with respect to different dialysis schedules. Nephrol Dial Transplant 1998, 13((Suppl 6)):10-14.
11. Cheung AK, Rocco MV, Yan G. Serum β-2 microglobulin levels predict mortality in dialysis patients: Results of the HEMO study. J Am Soc Nephrol 2006, 17:546-555.
12. Work Group. Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 2006, 48:S2-S90. Hemodialysis Adequacy
13. Ward RA, Greene T, Hartmann B, Samtleben W. Resistance to intercompartmental mass transfer limits β2-microglobulin removal by post-dilution hemodiafiltration. Kidney Int 2006, 69:1431-1437.
14. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol 1993, 4:1205-1213.
15. Dember LM, Jaber BL. Dialysis-related amyloidosis: Late finding or hidden epidemic? Semin Dial 2006, 19:105-109.
16. Jaradat MI, Moe SM. Effect of hemodialysis membranes on beta2-microglobulin amyloidosis. Semin Dial 2001, 14:107-112.
17. Miyata T, Jadoul M, Kurokawa K, van Ypersele D, Strihou C. Â2 microglobulin in renal disease. J Am Soc Nephrol 1998, 9:1723-1735.
18. Leypoldt JK. Kinetics of β2-microglobulin and phosphate during hemodialysis: Effects of treatment frequency and duration. Semin Dial 2005, 18:401-408.
19. Odell RA, Slowiaczek P, Moran JE, Schindhelm K. Beta2-microglobulin kinetics in end-stage renal failure. Kidney Int 1991, 39:909-919.
20. Leypoldt JK, Cheung AK, Deeter BR. Rebound kinetics of β2-microglobulin after hemodialysis. Kidney Int 1999, 56:1571-1577.
21. Leypoldt JK, Cheung AK, Deeter RB. Kinetics of urea and β2-microglobulin during and after short hemodialysis treatments. Kidney Int 2004, 66:1669-1676.
22. Raj SDC, Ouwendyk M, Francoeur R, Pierratos A. β2-M kinetics in nocturnal haemodialysis. Nephrol Dial Transplant 2000, 15:58-64.
23. Ronco C, Heifetz A, Fox K. Beta 2-microglobulin removal by synthetic dialysis membranes. Mechanisms and kinetics of the molecule. Int J Artif Organs 1997, 20:136-143.
24. Chanard J, Caudwell V, Valeire J. Kinetics of 131I-β2 microglobulin in hemodialysis patients: Assessment using total body counting. Artif Organs 1998, 22:574-580.
25. Su BH, Fu P, Li Q. Evaluation of polyethersulfone highflux hemodialysis membrane in vitro and in vivo. J Mater Sci Mater Med 2008, 19:745-751.
26. Gotch FA, Levin NW. Daily dialysis: The long and the short of it. Blood Purif 2003, 21:271-281.
27. Spalding EM, Chamney PW, Farrington K. Phosphate kinetics during hemodialysis: Evidence for biphasic regulation. Kidney Int 2002, 61:655-667.
28. Evenepoel P, Bammens B, Verbeke K, Vanrenterghem Y. Superior dialytic clearance of β2-microglobulin and P-cresol by high-flux hemodialysis as compared to peritoneal dialysis. Kidney Int 2006, 70:794-799.
29. Al-Hejaili F, Kortas C, Leitch R. Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration. J Am Soc Nephrol 2003, 14:2322-2328.
30. Leypoldt JK. Urea standard Kt/V urea for assessing dialysis treatment adequacy. Hemodial Int 2004, 8:193-197.